Abstract
SH Wedes, W Wijia, SAA Comhair. J Pediatr. 2011;159(2):248–255 To determine the usefulness of urinary bromotyrosine, a marker of eosinophil-catalyzed protein oxidation, in monitoring asthma control and predicting future exacerbations. There were 57 people enrolled from the Cleveland Clinic with a diagnosis of asthma between the ages of 5 and 21 years. Recruitment occurred from July to September 2006 and follow-up from August to November 2006. …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
